Latest papers

On the multivariate nature of brain metabolic impairment in Alzheimer's disease

A radiologic alcohol breathalyzer test.

[Hyperammonaemic encephalopathy due to valproic acid in the neonatal period]

[Consensus clinical practice guidelines of the Sociedad Andaluza de Epilepsia for the diagnosis and treatment of patients with their first epileptic seizure in emergencies]

Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction.

Teaching video NeuroImage: Chvostek sign with Fahr syndrome in a patient with hypoparathyroidism.

3-Nitropropionic acid-induced depression of spinal reflexes does not involve 5-hydroxytryptaminergic system in contrast to ischemia-induced depression in neonatal rat spinal cord in vitro.

Hyponatraemic encephalopathy as the initial presentation of Guillain-Barre syndrome.

Inborn errors of metabolism presenting as neonatal encephalopathy: practical tips for clinicians.

Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies.

'Succinic semialdehyde dehydrogenase deficiency: phenotype evolution in an adolescent patient at 20-year follow-up'.

Lysine induces lipid and protein damage and decreases reduced glutathione concentrations in brain of young rats.

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Valproate-induced hyperammonemic encephalopathy.

GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.

Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor.

[Glucose transporter type 1 deficiency: a treatable neuro-metabolic disorder]

Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways.

Interaction between intrapartum maternal fever and fetal acidosis increases risk for neonatal encephalopathy.

Yield of additional metabolic studies in neurodevelopmental disorders.